20:32:40 EDT Tue 30 Apr 2024
Enter Symbol
or Name
USA
CA



Perimeter Medical Imaging AI Inc
Symbol PINK
Shares Issued 65,025,739
Close 2023-12-13 C$ 0.80
Market Cap C$ 52,020,591
Recent Sedar Documents

Perimeter's S-Series OCT receives follow-on placement

2023-12-14 12:49 ET - News Release

Mr. Adrian Mendes reports

PERIMETER MEDICAL IMAGING AI ANNOUNCES FURTHER COMMERCIAL EXPANSION IN NORTH TEXAS WITH FOLLOW-ON PLACEMENT OF PERIMETER S-SERIES OCT WITHIN NATIONAL HEALTHCARE PROVIDER SYSTEM

Perimeter Medical Imaging AI Inc.'s flagship Perimeter S-Series OCT system has received a follow-on commercial placement at a new hospital site within one of the largest health care networks in North Texas, which is part of a major national health care system.

Perimeter's flagship product, the S-Series OCT (optical coherence tomography), is a pioneering medical imaging system that provides cross-sectional, real-time margin visualization of excised tissue specimens in the operating room at 10 times higher image resolution than X-ray and ultrasound, and 100 times greater image resolution than magnetic resonance imaging.

Adrian Mendes, Perimeter's chief executive officer, stated: "We believe this additional commercial placement within a major national health care system -- representing the fifth unit placed with this existing customer network -- demonstrates that surgeon end-users, as well as other stakeholders within the broader health care system, see the value of our technology and are recommending it to their peers. Our aim is to make Perimeter's innovative technology the standard of care in cancer surgery."

About Perimeter Medical Imaging AI Inc.

Based in Toronto, Canada, and Dallas, Tex., Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultrahigh-resolution, real-time, advanced imaging tools to address areas of high unmet medical need. Available across the United States, its Food and Drug Administration-cleared Perimeter S-Series OCT system provides real-time, cross-sectional visualization of excised tissues at the cellular level. The breakthrough-device-designated investigational Perimeter B-Series OCT with ImgAssist AI represents the company's next-generation artificial intelligence technology that is currently being evaluated in a pivotal clinical trial, with support from a grant of up to $7.4-million (U.S.) awarded by the Cancer Prevention and Research Institute of Texas. The company's ticker symbol PINK is a reference to the pink ribbons used during Breast Cancer Awareness Month.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.